In response to the Capital Market Commission's Letter numbered 3896/28.09.2007 with respect to an electronic press article regarding the "Contender of the Romanian pharmaceutical company Labormed", ALAPIS SA informs that in order to realize its business plan with the application of a part of the funds raised from the recently completed share capital increase via rights issue, the company assesses various investment opportunities for the participation or acquisition of companies with similar activity. It is in this manner that the company also examines the possibility of acquiring participation in this company.
At this point in time, this specific interest has not yet been realized and consequently any reference to this, is premature. In any case, the company respecting the legislation and the Athens Exchange Rules and Regulations, will promptly announce any regulated information.